Navigation Links
The Outlook for Pharmaceuticals in South East Asia
Date:12/13/2012

TaiwanThe government has been investing heavily in biotechnology research capability and this has helped facilitate the growth of the biologic sector. The plan is to double the annual output of the sector over the period 2009 to 2013. INDONESIADue to the sheer size of the population, Indonesia cannot simply be dismissed. The Indonesian pharmaceutical market is projected to grow at a high single-digit CAGR in US dollar terms during the forecast period, and it will be the sixth largest pharmaceutical market in the Asia Pacific region by 2016. However, despite the country possessing huge manufacturing capabilities, the complete lack of R&D in domestic companies could affect the market, especially if IPR regulations were tightened. Although multinationals will be unhappy at the legislation requiring all drugs in the Indonesian market to have been manufactured in Indonesia, it could potentially reduce costs in the long term for both the manufacturer and the consumer.

MALAYSIA

The Philippines has some of the highest drug prices in the world. Changes brought about by the controversial Cheaper Medicine Act have impacted the Philippines pharmaceutical market in a number of areas, including IP laws, competition and drug price control mechanisms. Since the Act's implementation, a considerable number of drugs have seen price reductions by up to a half. The immediate term will be the most volatile, as the government battles with the international pharmaceutical industry for ground in the market, which up until recently experienced a free-market policy with no price regulations in place.

SOUTH KOREAThe implementation of the EU-Korea Free Trade Agreement (FTA) will provide EU companies with better access to the South Korean pharmaceutical market by paving the way for elimination of tariffs on EU pharmaceutical exports to the country. The volume and value of EU pharmaceutical exports are expected to increase with the implementation of EU-Korea FTA, pos
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
2. Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry
3. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
4. The CMO Market Outlook to 2017
5. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
6. United States ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
7. United Kingdom ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
8. India Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures
9. United States Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures
10. China ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
11. India ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  Research and Benchmarking ... sixth Medical Affairs Roundtable on Thursday, ... a virtual roundtable to discuss "Medical Affairs, Role ... Best Practices, Medical Affairs Consortium provides Medical Affairs ... the key challenges they face. The consortium has ...
(Date:5/22/2015)... May 22 2015 /CNW/ - The Taskforce representing ... of all the hard work that the Minister and Health ... months. This program recognizes the needs of the thalidomide survivors, ... $75,000 a year, tax free, with annual adjustments for inflation. ... for annual payments of $100,000 based on the severity of ...
(Date:5/22/2015)... , May 22, 2015  Amgen (NASDAQ: ... has commenced termination of its participation in ... AstraZeneca (LON:AZN, STO:AZN and NYSE: AZN ... in development for patients with moderate-to-severe plaque ... decision was based on events of suicidal ...
Breaking Medicine Technology:Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
... BLUE BELL, Pa., Feb. 2, 2011 Inovio Pharmaceuticals, ... in the development of therapeutic and preventive vaccines against ... a scientific paper in the journal Human Vaccines ... of Inovio,s SynCon™ DNA vaccine for prostate cancer targeting ...
... LIONVILLE, Pa., Feb. 1, 2011 West Pharmaceutical Services, Inc. ... attend the UBS 21st Annual Global Healthcare Services Conference in ... business and outlook on Tuesday, February 8, 2011 at 1:00 ... Company,s presentation, as well as a copy of the presentation ...
Cached Medicine Technology:Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 2Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 3Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 4Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 5
(Date:5/23/2015)... 2015 Add High-Quality prismatic refractions into footage ... , It's as simple as dragging and dropping footage into ... for full effect. , Including over 80 stunning flares, ... sensors making this the ultimate bundle for adding prismatic refractions ... this package are movie files designed for Final Cut Pro ...
(Date:5/22/2015)... Utah (PRWEB) May 22, 2015 Mountain Point ... host a ribbon cutting ceremony on Friday, May 29, 2015 ... p.m. to 6 p.m. The new medical center, set to ... North Triumph Boulevard, Lehi, UT 84043. , “The opening ... our team and the Utah County community,” said Kent Loosle, ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Combination ... treatment option for chronic obstructive pulmonary disorder (COPD) ... plc and AstraZeneca plc as well as Germany’s ... share and position. But will market payers, clinicians ... already well-entrenched products to completely new ones? , ...
(Date:5/22/2015)... 2015 Coordinating care for people ... Historically providers have not been reimbursed or rewarded ... 2015, Medicare has paved the way by offering ... the launch of Oculus Health , an ... using the platform will now be able to ...
(Date:5/22/2015)... 22, 2015 ZH Healthcare ... solutions, announced today that Bill Lane, joins ZH’s ... developer of BlueEHS,a first of its kind, Freemium ... customizable Electronic Health Records (EHR) with an integrated ... telemedicine-enabled comprehensive patient portal, and more. Combined with ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2
... NRL: THE NEW STANDARDIZED SOURCE MATERIAL FOR THE PRODUCTION ... PRODUCTS USING ... Technology Limited has invited,Vystar Corporation to present its revolutionary ... Conference 2008 in Madrid in,January. "Vytex(TM) Natural Rubber ...
... Spain: In a surprising finding, American scientists have found ... as well as their single counterparts in certain aspects ... study, presented today (Wednesday) at the European Cancer Conference ... 489 patients with Barretts oesophagus, a non-cancerous condition linked ...
... that attacks cancer in an entirely new way has ... the disease and prolonging the lives of patients. , ... Conference (ECCO 14) in Barcelona found that giving the ... the amount of time patients survived without progression of ...
... and Vicksburg Plants Recognized as Premier,Facilities by the Association for ... ... Magazine, BATESVILLE, Ind., Sept. ... Hillenbrand Industries (HB),announced that its two metal manufacturing facilities and ...
... Proposals and Variations, LOS ANGELES, Sept. ... a leading e-health Wi-Fi PDA technology provider, ... and EMR applications,and the distributor of life ... products, announced today that its Board of ...
... newly incorporated subsidiary of Genomatix Software GmbH, has announced that ... the NCI/NIH for the fourth consecutive year. This years renewal ... was executed entirely between the US company and the NCI/NIH ... with our progress in putting the US company on its ...
Cached Medicine News:Health News:Global Latex Conference to Showcase Vytex(TM) NRL 2Health News:Married esophageal cancer patients fare worse in some quality of life aspects than single patients 2Health News:New type of drug shows promise in attacking melanoma in an innovative way 2Health News:Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations 2Health News:Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations 3Health News:InstaCare Corp. Reviewing M&A Plans 2
... drainage from the ureteropelvic junction to the ... segment with no sideports prevents postoperative narrowing ... of the ureteral wall to the stent. ... one-time use. CAUTION: Periodic evaluation is advised; ...
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... silicone or Silitek, ACMI Single J ... healing after surgery. Following cystectomy, the ... supports the ileal intestinal anastomosis, and ... leakage. Following ureteroscopy, the Single J ...
... The V-Max™ Roller Bar Electrode provides ... and improve visibility during TURP procedures. The ... surface with holes. The holes have circular ... tissue ablation. This patented design was developed ...
Medicine Products: